People with chronic kidney disease (CKD) need better and more effective treatments. Over 37 million Americans have kidney disease and most of them don't even know it. Kidney failure is the 9th leading cause of death in the United States. There are almost 555,000 people on dialysis in the United States, and another almost 210,000 individuals living with a kidney transplant. Americans need a bigger investment in kidney research to understand and halt the progression of CKD - or even stop it from happening altogether. The NIH institute that is focused on kidney research is the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK).
On July 27, 2021, the U.S. House of Representatives passed H.R. 4502. The legislation included $49 billion for the NIH, with a 5% increase to the NIDDK. The increase is needed to understand kidney disease better.
The bill also included $5 million for KidneyX for FY 2022. The KidneyX Innovation Accelerator is a public/private partnership between the American Society of Nephrology and the U.S. Department of Health and Human Services. The partnership's goal is to drive innovation in the diagnosis and treatment of kidney diseases by identifying promising technologies through competitions and awarding funding to the winners.
This legislation has now been referred to the Senate. Please urge your Senators to vote for adequate funding for kidney research when these yearly bills are debated and enacted.